Funding, News and Announcements

Projects that will be considered for Pfizer support will focus on:

• Educating on the evolving treatment landscape (i.e. genetic medicine, rebalancing strategies) for hemophilia to improve the understanding of these novel approaches and their potential clinical applicability.
• Discussing shared decision making (SDM) and practical approaches on how SDM can be incorporated into hemophilia patient care.
• Educating on the benefits of omnichannel healthcare strategies which can provide a seamless, personalized service and patient care experience.
• Sharing knowledge and best practices (i.e. staff training, SOP, follow-up care) on how Hemophilia Treatment Centers (HTCs) and multidisciplinary teams are preparing for novel therapies in development.
• Advancing patient education on the evolving hemophilia treatment landscape and improving patients’ empowerment and ability to make informed decisions about their care.

Funding Range: Individual projects requesting up to $100,000 will be considered.

Applications will be accepted on a rolling basis through September. Please refer to the Request for Proposals documents for further details.

Contact Details

Internal: ird@dal.ca
External: Amanda Stein (amanda.j.stein@pfizer.com@pfizer.com), with the subject line “Hemophilia Education.”

Deadlines

Internal:  A minimum of ten (10) business days before any external deadlines.
External: Applications will be accepted on a rolling basis through September

The grants facilitator for your faculty can be found on the staff contact page. For additional resources, click here for guidance on internal deadlines and submission processes.